A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 31/4015 (2006.01) A61K 31/405 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2577213
A method of combating prostate cancer in a mammalian individual, the method comprising administering an inhibitor of glycogen synthase kinase-3 (GSK-3), or a polynucleotide which encodes an inhibitor of GSK-3, to the individual. A further anti-cancer agent can also be administered. Use of an inhibitor of GSK- 3, or a polynucleotide which encodes an inhibitor of GSK-3, in the preparation of a medicament for combating prostate cancer. The medicament may contain a further anti-cancer agent.
L'invention concerne un procédé permettant de combattre le cancer de la prostate chez un être mammifère. Ce procédé consiste à administrer à cet être un inhibiteur de glycogène synthase kinase-3 (GSK-3), ou un polynucléotide qui est codant pour un inhibiteur de GSK-3. Un autre agent anti-cancer peut également être administré. L'invention concerne également l'utilisation d'un inhibiteur de GSK-3, ou d'un polynucléotide qui est codant pour un inhibiteur de GSK-3, dans la préparation d'un médicament pour combattre le cancer de la prostate. Ce médicament peut contenir un autre agent anti-cancer.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Imperial Innovations Limited
LandOfFree
Use of gsk-3 inhibitors for the treatment of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of gsk-3 inhibitors for the treatment of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of gsk-3 inhibitors for the treatment of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1441629